The most common objection to TRT is cost. At $100-$200 per month for most online clinic protocols — $1,200-$2,400 per year — it's not trivial. For uninsured men or those whose insurance won't cover testosterone, it feels like a luxury expense.
But this framing is backwards. The question isn't "can I afford TRT?" The question is "can I afford not to treat low testosterone?" Because the clinical data on untreated hypogonadism paints a picture of cascading health consequences that make $150/month look like a bargain.
The Metabolic Cost
Low testosterone isn't just a quality-of-life issue — it's a metabolic disorder with quantifiable downstream health consequences. Men with untreated hypogonadism face dramatically elevated risks across nearly every major disease category:
| Condition | Increased Risk with Low T | Average Annual Treatment Cost (US) |
|---|---|---|
| Type 2 diabetes | 52% higher likelihood | $9,600 (direct medical costs) |
| Obesity / metabolic syndrome | 69% higher likelihood of obesity | $1,800-$3,500 (medical costs attributable to obesity) |
| Cardiovascular disease | Elevated risk (multiple mechanisms) | $18,000+ (heart attack), $30,000+ (stroke) |
| Osteoporosis / fractures | Significant bone density loss over time | $12,000-$40,000 (hip fracture with rehab) |
| Depression | 2-3x higher prevalence | $3,000-$6,000/year (treatment + productivity loss) |
| All-cause mortality | ~2x risk of premature death | N/A |
The all-cause mortality statistic is the most sobering. Multiple large observational studies have found that men with low testosterone are approximately twice as likely to die prematurely as men with normal levels, even after adjusting for age, BMI, and comorbidities. The December 2025 FDA expert panel cited this data when recommending expanded TRT access.
The Productivity Cost
Low testosterone doesn't just cause disease — it impairs function. The symptoms that drive men to seek treatment (fatigue, brain fog, low motivation, poor concentration, decreased physical capacity) have real economic consequences that rarely get quantified.
A man with untreated hypogonadism who is 20% less productive at work, misses an additional 3-5 sick days per year, passes on a promotion because he lacks the energy or confidence to pursue it, and foregoes exercise because the physical capacity isn't there — the cumulative economic impact of these losses dwarfs the cost of treatment. Conservative estimates put the annual productivity cost of symptomatic low testosterone at $5,000-$15,000 per person, depending on the severity of symptoms and the nature of their work.
The Relationship Cost
This one doesn't show up in healthcare cost analyses, but it's where many men feel the impact most acutely. Low libido, erectile dysfunction, irritability, emotional blunting, and withdrawal from social activity — these are not abstract clinical outcomes. They are relationship stressors with real consequences.
Men with untreated hypogonadism report significantly lower relationship satisfaction, higher rates of relationship conflict, and more frequent sexual dysfunction complaints from partners. While these can't be reduced to a dollar figure, the downstream effects (couples therapy at $150-$300/session, increased divorce risk, reduced family functioning) are non-trivial both financially and personally.
The Comparison: TRT Cost vs Cost of Not Treating
| Category | TRT (Annual Cost) | Untreated Low T (Estimated Annual Cost) |
|---|---|---|
| Treatment / clinic fees | $1,200-$2,400 | $0 |
| Lab work | $200-$600 (often included in clinic fee) | $0 (but problems go unmonitored) |
| Downstream metabolic disease risk | Reduced | $2,000-$10,000+ (diabetes management, CV risk) |
| Lost productivity | Improved | $5,000-$15,000 (conservative estimate) |
| Mental health treatment | Often reduced or eliminated | $1,000-$6,000 (therapy, medications) |
| Gym / fitness outcomes | Dramatically improved per hour invested | Poor returns on effort; gym membership potentially wasted |
| Quality-adjusted life years | Gained | Lost |
The 9,000-Patient Real-World Study
A 2026 longitudinal study of over 9,000 men published in the World Journal of Men's Health found that testosterone therapy was associated with significant improvements in metabolic parameters, sexual function, and quality of life metrics over long-term follow-up. The authors noted that real-world outcomes data increasingly supports early intervention rather than watchful waiting — suggesting that the "wait and see" approach many primary care doctors take may actually increase long-term healthcare costs.
The Insurance Paradox
One of the frustrations of the current system is that insurance companies often won't cover TRT (or make coverage difficult to obtain) despite the downstream cost savings. A man who pays $150/month out of pocket for testosterone therapy may save his insurer thousands in avoided diabetes management, cardiovascular interventions, and mental health treatment. The FDA's April 2026 announcement — encouraging expanded indications for TRT — may eventually improve insurance coverage, but for now, many men are stuck paying out of pocket for treatment that would save the healthcare system money.
In the meantime, FSA and HSA accounts can be used for TRT costs, effectively reducing the price by your marginal tax rate (typically 22-35% for most men considering TRT). A $150/month clinic fee becomes $100-$117/month after tax savings.
The Bottom Line
Framing TRT as an expense misses the full picture. Untreated low testosterone is not a cost-free alternative — it carries its own price tag in metabolic disease risk, lost productivity, diminished quality of life, and potentially shorter lifespan. For men with clinically confirmed hypogonadism and significant symptoms, the economic case for treatment is overwhelmingly positive. The cost of TRT isn't what you pay each month — it's the gap between that and what you'd pay in health consequences if you did nothing.
Find an Affordable Clinic
TRT costs vary widely. Compare all-inclusive pricing across the top providers.
Use the Cost Calculator →Related reading: TRT FSA and HSA · TRT Cost Per Month · Testosterone and Insulin Resistance